Research map: Elevated Plasma GDF-15 Levels are Associated with the Immune Non-Responder Phenotype in People with HIV

Back to the article

Papers in this map

  1. Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease · Kai Christoph Wollert · 2016 · 566 citations · Cited by this paper
  2. Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity · 2026 · Related
  3. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies · Adam Trickey · 2023 · 540 citations · Cited by this paper
  4. Use of Isavuconazole in the Treatment of Cryptococcosis: A Real-World Case Series · 2026 · Related
  5. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders · Xiaodong Yang · 2020 · 348 citations · Cited by this paper
  6. Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C · 2026 · Related
  7. Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets · Luc Rochette · 2020 · 190 citations · Cited by this paper
  8. Multicenter Real-World Outpatient Use of Intravenous Omadacycline · 2026 · Related
  9. La cohorte de la red española de investigación en sida y su biobanco: organización, principales resultados y pérdidas al seguimiento · Paz Sobrino‐Vegas · 2011 · 160 citations · Cited by this paper
  10. Early Warning and Behavioural Intervention on the Cardiovascular Disease Risk in People Living with HIV: A Multicentre Non-Randomized Controlled Trial · 2026 · Related
  11. The Spanish HIV BioBank: a model of cooperative HIV research · Isabel García-Merino · 2009 · 153 citations · Cited by this paper
  12. HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort · 2026 · Related
  13. Definition of Immunological Nonresponse to Antiretroviral Therapy: A Systematic Review · Rita Rb-Silva · 2019 · 69 citations · Cited by this paper
  14. Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis · 2026 · Related
  15. Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis · Jojo Reyes · 2023 · 55 citations · Cited by this paper
  16. Hospitalisation Burden of Human Metapneumovirus and Respiratory Syncytial Virus in Adults by Age and Comorbidity Status in Scotland: A Retrospective Analysis · 2026 · Related
  17. Recent advances in poor HIV immune reconstitution: what will the future look like? · Wenyuan Zhang · 2023 · 45 citations · Cited by this paper
  18. Glecaprevir/Pibrentasvir for Acute Hepatitis C Virus Infection in Individuals with a History of Prior Hepatitis C Infection · 2026 · Related
  19. Two-threshold defined immune non-responders are associated with long-term morbidity in people with HIV: a prospective cohort study · Xiaorui Li · 2025 · 13 citations · Cited by this paper
  20. Clinical and Economic Inpatient Burden of Influenza and Influenza-Like Illness in Germany 2019–2025: Analysis of Nationwide Hospital Data · 2026 · Related
  21. Plasma GDF-15 Levels Are Associated With HIV Reservoir Markers Independently of Inflammation in People With HIV on Antiretroviral Therapy · Stéphane Isnard · 2026 · 3 citations · Cited by this paper
  22. Elevated Plasma GDF-15 Levels Are Associated with Aging, Multimorbidity, and Tobacco Exposure in People with HIV · Aida López López · 2026 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)